BMC Dermatology最新文献

{"title":"Odonto-onycho-dermal dysplasia in a patient homozygous for a WNT10A nonsense mutation and mild manifestations of ectodermal dysplasia in carriers of the mutation","authors":"A. B. Krøigård, O. Clemmensen, H. Gjørup, J. Hertz, A. Bygum","doi":"10.1186/s12895-016-0040-7","DOIUrl":"https://doi.org/10.1186/s12895-016-0040-7","url":null,"abstract":"","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"31 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-016-0040-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66135989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"BMC Dermatology Reviewer Acknowledgement, 2015","authors":"Guangde Tu","doi":"10.1186/s12895-016-0039-0","DOIUrl":"https://doi.org/10.1186/s12895-016-0039-0","url":null,"abstract":"","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-016-0039-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66135843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Estimation of individual cumulative ultraviolet exposure using a geographically-adjusted, openly-accessible tool","authors":"G. Zhu, I. Raber, Sukolsak Sakshuwong, Shufeng Li, Angela S. Li, Caroline Z. Tan, A. Chang","doi":"10.1186/s12895-016-0038-1","DOIUrl":"https://doi.org/10.1186/s12895-016-0038-1","url":null,"abstract":"","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2016-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-016-0038-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66135791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Risk factors associated with abscess formation among patient with leg erysipelas (cellulitis) in sub-Saharan Africa: a multicenter study","authors":"P. Pitché, B. Saka, Ahy Boubacar Diatta, O. Faye, B. Diané, A. Sangaré, P. Niamba, C. Mandengue, L. Kobengue, A. Diop, F. Ly, M. Dieng, A. Dicko, M. Soumah, M. Cissé, S. Kourouma, I. Kouassi, T. Boukari, S. Akakpo, D. Landoh, K. Tchangaï‐Walla","doi":"10.1186/s12895-015-0037-7","DOIUrl":"https://doi.org/10.1186/s12895-015-0037-7","url":null,"abstract":"","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2015-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0037-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"66135721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Adherence to drug treatments and adjuvant barrier repair therapies are key factors for clinical improvement in mild to moderate acne: the ACTUO observational prospective multicenter cohort trial in 643 patients.","authors":"Raúl de Lucas,&nbsp;Gerardo Moreno-Arias,&nbsp;Montserrat Perez-López,&nbsp;Ángel Vera-Casaño,&nbsp;Sonia Aladren,&nbsp;Massimo Milani","doi":"10.1186/s12895-015-0036-8","DOIUrl":"https://doi.org/10.1186/s12895-015-0036-8","url":null,"abstract":"<p><strong>Background: </strong>In acne, several studies report a poor adherence to treatments. We evaluate, in a real-life setting conditions, the impact of compliance to physician's instructions, recommendations and adherence to the treatments on clinical outcome in patients with mild to moderate acne in an observational, non-interventional prospective study carried out in 72 Dermatologic Services in Spain (ACTUO Trial).</p><p><strong>Methods: </strong>Six-hundred-forty-three subjects were enrolled and 566 patients (88 %) completed the 3 study visits. Study aimed to evaluate the impact of adherence (assessed with ECOB scale) on clinical outcome, as well as how the use of specific adjuvant treatments (facial cleansing, emollient, moisturizing and lenitive specific topical products) influences treatment's adherence and acne severity (0-5 points score). Recommendation of specific adjuvant skin barrier repair products was made in 85.2 %.</p><p><strong>Results: </strong>Overall, clinical improvement was observed throughout follow-up visits with an increased proportion of patients who reported reductions of ≥50 % on the total number of lesions (2 months: 25.2 %; 3 months: 57.6 %) and reductions of severity scores (2.5, 2.0 and 1.3 at 1, 2 and 3 months after treatment, respectively). Adherence to treatment was associated with a significant reduction on severity grading, a lower number of lesions and a higher proportion of patients with ≥50 % improvement.</p><p><strong>Conclusions: </strong>Good adherence to medication plus adherence to adjuvants was significantly associated with a higher clinical improvement unlike those that despite adherence with medication had a low adherence to adjuvants. A good adherence to adjuvant treatment was associated with improved adherence and better treatment outcomes in mild to moderate acne patients. (ISRCTN Registry: ISRCTN14257026).</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"17"},"PeriodicalIF":0.0,"publicationDate":"2015-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0036-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33997808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Skin diseases in pediatric patients attending a tertiary dermatology hospital in Northern Tanzania: a cross-sectional study.","authors":"Samson K Kiprono,&nbsp;Julia W Muchunu,&nbsp;John E Masenga","doi":"10.1186/s12895-015-0035-9","DOIUrl":"https://doi.org/10.1186/s12895-015-0035-9","url":null,"abstract":"<p><strong>Background: </strong>Skin diseases affect 21-87 % of children in developing countries in Africa. However, the spectrum of the skin diseases varies from region to region due to several factors such as genetics, socioeconomic and environmental. The aim of this study was to determine the spectrum of childhood skin diseases in Tanzania.</p><p><strong>Methods: </strong>We conducted a prospective hospital- based cross-sectional study between September 2012 and August 2013 at a tertiary referral dermatology clinic. Children younger than 14 years presenting with new skin conditions were recruited. Diagnosis was mainly done clinically, but if the diagnosis was not clinically clear, further investigations were undertaken accordingly.</p><p><strong>Results: </strong>A total of 340 patients were recruited of which 56 (16.5 %) had more than one skin condition. Both genders were equally affected. Infections and infestations accounted for the majority (43.5 %, n = 177) of the skin conditions followed by eczematous dermatitis (28.5 %, n = 116) and pigmentary disorders (7.4 %, n = 30). Among the 152 infectious skin diseases, fungal infections predominated (50.7 %, n = 77) in the infectious group followed by bacterial (29.6 %, n = 45), and viral (19.7 %, n = 30).</p><p><strong>Conclusions: </strong>Skin infections are still the main cause of dermatological consultations in children although with a reduced prevalence. Inflammatory skin conditions are increasing and can be attributed to improved socioeconomic status and HIV pandemic.</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"16"},"PeriodicalIF":0.0,"publicationDate":"2015-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0035-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34062505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Magnitude and associated factors of Atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia.","authors":"Abraham Getachew Kelbore,&nbsp;Workalemahu Alemu,&nbsp;Ashenafi Shumye,&nbsp;Sefonias Getachew","doi":"10.1186/s12895-015-0034-x","DOIUrl":"https://doi.org/10.1186/s12895-015-0034-x","url":null,"abstract":"<p><strong>Background: </strong>Atopic Dermatitis (AD) is now a day's increasing in prevalence globally. A Prevalence of 5-25 % have been reported in different country. Even if its prevalence is known in most countries especially in developing countries there is scarcity with regard to prevalence and associated risk factors of AD among children in Ethiopia settings. The aim of this study was to determine the magnitude and associated factors of atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia.</p><p><strong>Methods: </strong>A facility-based cross-sectional study design was conducted among 477 children aged from 3 months to 14 years in Ayder referral hospital from July to September, 2014. A systematic random sampling technique was used to identify study subjects. Descriptive analysis was done to characterize the study population. Bivariate and multivariate logistic regression was used to identify factors associated with AD. The OR with 95 % CI was used to show the strength of the association and a P value < 0.05 was used to declare the cut of point in determining the level of significance.</p><p><strong>Results: </strong>Among the total respondents, 237 (50.4 %) were males and 233 (49.6 %) were females. The magnitude of the atopic dermatitis was found to be 9.6 % (95 % CI: 7.2, 12.5). In multivariate logistic regression model, those who had maternal asthma (AOR: 11.5, 95 % CI:3.3-40.5), maternal hay fever history (AOR: 23.5, 95 % CI: 4.6-118.9) and atopic dermatitis history (AOR: 6.0, 95 % CI:1.0-35.6), Paternal asthma (AOR: 14.4, 95 % CI:4.0-51.7), Paternal hay fever history (AOR: 13.8, 95 % CI: 2.4-78.9) and personal asthma (AOR: 10.5, 95 % CI:1.3-85.6), and hay fever history (AOR: 12.9, 95 % CI:2.7-63.4), age at 3 months to 1 year (OR: 6.8, 95 % CI: 1.1-46.0) and weaning at 4 to 6 months age (AOR: 3.9, 95 % CI:1.2-13.3) were a significant predictors of atopic dermatitis.</p><p><strong>Conclusion: </strong>In this study the magnitude of atopic dermatitis was high in relation to other studies conducted so far in the country. Maternal, paternal, personal asthma, hay fever histories, maternal atopic dermatitis history, age of child and age of weaning were independent predicators of atopic dermatitis. Hence, the finding alert a needs of strengthening the national skin diseases prevention and control services in particular in skin care of children related to atopic dermatitis and others. In avoiding early initiation of supplementary feeding specially with personal and families with atopic problem needs further attention of prevention activities.</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"15"},"PeriodicalIF":0.0,"publicationDate":"2015-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0034-x","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34117549","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Role models in a preventive program for hand eczema among healthcare workers: a qualitative exploration of their main tasks and associated barriers and facilitators.","authors":"Anne M Bruinewoud,&nbsp;Esther W C van der Meer,&nbsp;Joost W J van der Gulden,&nbsp;Johannes R Anema,&nbsp;Cécile R L Boot","doi":"10.1186/s12895-015-0033-y","DOIUrl":"https://doi.org/10.1186/s12895-015-0033-y","url":null,"abstract":"<p><strong>Background: </strong>Role models often play a role when implementing guidelines in healthcare. However, little is known about how role models perform their respective roles, or about which factors may hamper or enhance their functioning. The aim of the present study was therefore to investigate how role models perform there role as a part of a multifaceted implementation strategy on the prevention of hand eczema, and to identify barriers and facilitators for the performing of their role.</p><p><strong>Methods: </strong>The role models were selected to become a role model and received a role model training. All role models worked at a hospital. In total, 19 role models, were interviewed. A topic list was used focussing on how the role models performed their role and what they experienced to be facilitators and barriers for their role. After coding the interviews, the codes were divided into themes.</p><p><strong>Results: </strong>This study shows that the main tasks perceived by the role models were to raise awareness, to transfer information, to interact with colleagues about hand eczema, to provide material, and to perform coordinating tasks. Barriers and facilitators were whether the role suited the participant, affinity with the topic, and risk perception.</p><p><strong>Conclusions: </strong>Most role models performed only the tasks they learned during their training. They mentioned a wide range of barriers and facilitators for the performing of their role. To enhance the functioning of the role models, a suggestion would be to select role models by taking into account prior coaching experience.</p><p><strong>Trial registration: </strong></p><p><strong>Trial registration number: </strong>NTR2812.</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2015-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0033-y","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33935651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up of a randomised controlled trial.","authors":"Melanie Rae Simpson,&nbsp;Christian Kvikne Dotterud,&nbsp;Ola Storrø,&nbsp;Roar Johnsen,&nbsp;Torbjørn Øien","doi":"10.1186/s12895-015-0030-1","DOIUrl":"https://doi.org/10.1186/s12895-015-0030-1","url":null,"abstract":"<p><strong>Background: </strong>Perinatal probiotics supplementation has been shown to be effective in the primary prevention of atopic dermatitis (AD) in early childhood, although the long term effects of probiotics on AD and other allergic diseases is less certain. We have previously reported a significant reduction in the cumulative incidence of AD at 2 years after maternal probiotic supplementation. In this study we present the effects of perinatal probiotics given to women from a general population on allergy related diseases in their offspring at 6 years.</p><p><strong>Methods: </strong>Four hundred and fifteen pregnant women were randomised to receive probiotic or placebo milk in a double-blinded trial from 36 week gestation until 3 months postpartum. Probiotic milk contained Lactobacillus rhamnosos GG, L. acidophilus La-5 and Bifidobacterium animalis subsp. lactis Bb-12. At 6 years, children were re-assessed for AD, atopic sensitisation, asthma and allergic rhinoconjunctivitis (ARC).</p><p><strong>Results: </strong>At 6 years, 81 and 82 children were assessed for AD in the probiotic and placebo groups, respectively. In a multiple imputation analysis, there was as trend towards a lower cumulative incidence of AD in the probiotic group compared to the placebo group (OR 0.64, 95 % CI 0.39-1.07, p = 0.086; NNT = 10). This finding was statistically significantly in the complete case analysis (OR 0.48, 95 % CI 0.25-0.92, p = 0.027, NNT = 6). The prevalence of asthma and atopic sensitisation, and the cumulative incidence of ARC were not significantly affected by the probiotic regime at 6 years of age.</p><p><strong>Conclusions: </strong>Maternal probiotic ingestion alone may be sufficient for long term reduction in the cumulative incidence of AD, but not other allergy related diseases.</p><p><strong>Trial registration: </strong>ClinicalTrials.gov identifier: NCT00159523.</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"13"},"PeriodicalIF":0.0,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0030-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33887838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Features of human scabies in resource-limited settings: the Cameroon case.","authors":"Emmanuel Armand Kouotou,&nbsp;Jobert Richie N Nansseu,&nbsp;Isidore Sieleunou,&nbsp;Defo Defo,&nbsp;Anne-Cécile Zoung-Kanyi Bissek,&nbsp;Elie Claude Ndjitoyap Ndam","doi":"10.1186/s12895-015-0031-0","DOIUrl":"https://doi.org/10.1186/s12895-015-0031-0","url":null,"abstract":"<p><strong>Background: </strong>The persistent high prevalence of human scabies, especially in low- and middle-income countries prompted us to research the sociodemographic profile of patients suffering from it, and its spreading factors in Cameroon, a resource-poor setting.</p><p><strong>Methods: </strong>We conducted a cross-sectional survey from October 2011 to September 2012 in three hospitals located in Yaoundé, Cameroon, and enrolled patients diagnosed with human scabies during dermatologists' consultations who volunteered to take part in the study.</p><p><strong>Results: </strong>We included 255 patients of whom 158 (62 %) were male. Age ranged from 0 to 80 years old with a median of 18 (Inter quartile range: 3-29) years. One to eight persons of our patients' entourage exhibited pruritus (mean = 2.1 ± 1.8). The number of persons per bed/room varied from 1 to 5 (mean = 2.1 ± 0.8). The first dermatologist's consultation occurred 4 to 720 days after the onset of symptoms (mean = 77.1 ± 63.7). The post-scabies pruritus (10.2 % of cases) was unrelated to the complications observed before correct treatment (all p values > 0.05), mainly impetiginization (7.1 %) and eczematization (5.9 %).</p><p><strong>Conclusion: </strong>Human scabies remains preponderant in our milieu. Populations should be educated on preventive measures in order to avoid this disease, and clinicians' knowledges must be strengthened for its proper diagnosis and management.</p>","PeriodicalId":9014,"journal":{"name":"BMC Dermatology","volume":"15 ","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2015-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s12895-015-0031-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33860730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}